10X Fund, L.P. - 31 Dec 2024 Form 5 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
10%+ Owner
Signature
/s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP
Issuer symbol
GALT
Transactions as of
31 Dec 2024
Net transactions value
-$76,500
Form type
5
Filing time
10 Oct 2025, 18:27:00 UTC
Previous filing
31 Jan 2023
Next filing
12 Nov 2025

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
10X Fund, L.P. 10%+ Owner 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA, /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP 10 Oct 2025 0001453356
10X Capital Management, LLC 10%+ Owner 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA, /s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC 10 Oct 2025 0001457247

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Sale $65,248 -21,323 -0.36% $3.06 5,925,884 22 Apr 2024 By 10X Fund, LP F1
transaction GALT Common Stock Sale $11,252 -3,677 -0.06% $3.06 5,922,207 23 Apr 2024 By 10X Fund, LP F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.